Synairgen plc (AIM: SNG)
London
· Delayed Price · Currency is GBP · Price in GBX 1.722
-0.278 (-13.90%)
Jan 20, 2025, 3:58 PM GMT+1
Synairgen Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
36
Market Cap
18.97M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 38.20B |
| GSK plc | 31.31B |
| Haleon | 11.24B |
| Smith & Nephew | 4.46B |
| ConvaTec Group | 1.74B |
| Hikma Pharmaceuticals | 2.39B |
| HUTCHMED (China) | 483.31M |
| Oxford Nanopore Technologies | 167.75M |
Synairgen News
- 13 days ago - AIM Market Roundup: Mkango, N4 Pharma, Minoan - The Armchair Trader
- 15 days ago - Small Cap Stocks: Borders & Southern, GENIP, Smarttech 247 - The Armchair Trader